Rather a derogatory posting. From little acorns big oak trees grow. They are proceeding in a logical manner and you start small. They know what they are doing, indeed the MD/CEO? was on the Neuren team when it was 10c on a good day and through their logical small start, methodical approach that stock went to $10+.
Whilst we are doing the GLP preliminary work The US Army Walter Reed Centre is undergoing testwork as well and we should get a readout before too long, And yes, WR use rat(s) as well. WR is the LEADING brain injury research Centre in the USA. A positive result from their prelim work will hold us in good stead for FDA approval to go to Phase 1/2. After all, who would disagree with the US Army ! As for funding, an all clear from WR and no GLP issues would I expectasily funding from the US Army and/ or other agencies in the USA. The US Army has said Traumatic Brain Injury is their Number 1 issue when it comes to medical research. The risk/reward scenarion here is too compelling to ignore.
- Forums
- ASX - By Stock
- NYR
- Ann: Brain Injury Program GLP Studies Further Update
Ann: Brain Injury Program GLP Studies Further Update, page-4
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.8¢ |
Change
0.021(23.6%) |
Mkt cap ! $17.85M |
Open | High | Low | Value | Volume |
8.8¢ | 11.0¢ | 8.8¢ | $181.7K | 1.823M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 126321 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 73044 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 140321 | 0.105 |
3 | 224000 | 0.100 |
1 | 26000 | 0.097 |
3 | 329669 | 0.095 |
1 | 12000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 321202 | 6 |
0.115 | 213490 | 4 |
0.120 | 462966 | 7 |
0.125 | 65000 | 3 |
0.130 | 379956 | 5 |
Last trade - 11.53am 03/10/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |